在基与基于蛋白质的基质上,SARS-CoV-2主要蛋白酶变体的特异性差异
Fernanda R Rocho1,2, Scott J Snipas1, Anwar Shamim2
1Cell and Molecular Biology of Cancer Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
The FEBS journal
|October 16, 2023
概括
SARS-CoV-2 主蛋白酶 (Mpro) 突变不会显著改变它在基质上的活性. 针对原始菌株的抑制剂.
科学领域:
- 病毒学 病毒学
- 生物化学 生物化学
- 药物发现 药物发现 药物发现
背景情况:
- SARS-CoV-2 主蛋白酶 (Mpro) 对于病毒复制至关重要,也是关键的治疗点.
- 新出现的SARS-CoV-2变种在Mpro序列中具有突变,这引发了对药物疗效的担忧.
研究的目的:
- 研究SARS-CoV-2变种 (Beta1,Beta2,Omicron) 中Mpro突变对蛋白酶活性和基质特异性的影响.
- 为了确定Mpro突变是否会对现有的抑制剂产生耐药性.
主要方法:
- 从原始SARS-CoV-2菌株及其变种 (Beta1,Beta2,Omicron) 中表达Mpro.
- 使用基于蛋白质和基质的Mpro活性分析.
主要成果:
- Mpro变体在基于蛋白质的基质上表现出不同的活性.
- 当使用基质时,观察到活动的最小差异.
- Mpro突变没有显著改变催化部位与基质的相互作用.
结论:
- 在SARS-CoV-2 Mpro中发生的突变对基质裂变有很小的影响,并且不会对抑制产生抗性.
- 现有的Mpro抑制剂可能会对当前和未来的SARS-CoV-2变种保持有效.
- 由于罕见,低影响的突变,Mpro仍然是一个可行的治疗标.
相关概念视频
Conservation of Protein Domains Over Different Proteins
10.9K
Protein domains are small structurally independent units that are part of a single amino acid chain. Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
10.9K
The Proteasome
8.7K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.7K
Protein Complexes with Interchangeable Parts
2.6K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.6K


